Combined asthma medication therapy shown to reduce attacks

February 6, 2012

A Henry Ford Hospital study has found that using two types of common asthma medications in combination reduces severe asthma attacks.

Researchers say using long-acting beta-agonists (LABAs) in fixed-dose combination with (ICS) appear to reduce asthma attacks as well as or better than corticosteroids alone. who had in greatest benefits were:

  • Patients 18 and older
  • African-American patients
  • Patients with moderate to severe asthma
The study is believed to be the first to estimate actual patient use when assessing the effectiveness of these medications in reducing severe asthma attacks. Researchers analyzed data of 1,828 who received an ICS/LABA combination or an ICS alone between January 2003 and December 2010.

The findings are published online in the Journal of Allergy and Clinical Immunology.

Researchers say the findings are a key development in asthma treatment involving LABAs as a potential therapy. The safety of LABAs by themselves as a therapy were called into question after a high number of deaths and serious asthma attacks were reported in the Salmeterol Multicenter Asthma Research Trial, forcing it to be abruptly stopped in 2003. In this study, African-American patients, in particular, fared worse than using a LABA inhaler as compared to placebo.

As a result, the U.S. suggested limiting the use of LABAs to patients already taking an asthma controller such as an inhaled corticosteroid. A series of clinical trials are under way investigating the benefits of LABA in combination with ICS treatment, and results are not expected until 2017.

"Until those trials are completed, our study provides important interim evidence that a fixed-dose combination therapy can reduce ," says Karen Wells, MPH, a Henry Ford researcher and the study's lead author.

Added Keoki Williams, M.D., MPH, associate director of Henry Ford's Center for Health Policy and Health Services Research: "We are especially encouraged by the benefits experienced by African-American patients. Our findings suggest that inhaled long-acting beta-agonists are broadly beneficial for treating asthma when they are simultaneously administered with an inhaled corticosteroid."

More than 20 million Americans, or approximately 1 in 15, suffer from asthma, which accounts for nearly 500,000 hospitalizations in the United States annually, according to the American Academy of Allergy, Asthma and Immunology.

Explore further: Against expectations, genetic variation does not alter asthma treatment response

More information: http://www.jacionline.org/article/S0091-6749%2811%2902943-5/abstract

Related Stories

Study: Getting patients to take their asthma meds

June 15, 2010

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit.

Discovery of asthma cause could help treat sufferers

October 5, 2011

(Medical Xpress) -- Scientists at the University of Bath have found a new cause of severe asthma that could help develop a treatment and potentially prevent the 1100 asthma deaths each year in the UK.

Recommended for you

New drug to fight fatal but neglected tropical disease

August 31, 2016

In a breakthrough for those infected by the parasites that cause sleeping sickness, a young Queensland researcher has identified a compound that kills the parasites in the lab without having any toxic effect on human cells.

Traces of Ebola virus linger longer than expected in semen

August 31, 2016

Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...

Researchers discover a drug for a tropical disease

August 30, 2016

Researchers at the University of Georgia are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. By working to improve chemical entities already ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.